生命科学资讯

Rare pediatric PRV program reauthorized until 2029 via government funding law

GSK’s new CEO eyes more dealmaking, intense pipeline inspection

Veradermics lands $256M IPO for oral Rogaine

Midi Health raises $100M as it plans expansion into urgent care, research

Hims adds Grail's cancer test amid questions about widespread use

Novartis says generics to erode $4B from 2026 sales

Embattled Novo Nordisk considers buying a monthly GLP-1 to bolster portfolio

FDA seeks withdrawal of Amgen's Tavneos, company says it won't pull drug

UK’s health department expected to spend £1B in pharma trade deal with US

Novo expects sales to fall in 2026, triggering selloff

'Turning around the Titanic': How the incoming PBM reforms will transform CMS

What's driving health tech M&A

China startup AccurEdit raises $75M for gene editing therapies

Daiichi ends work on an ADC; Layoffs at GSK's R&D unit

Ultragenyx unwraps data that may be central to its gene therapy resubmission

Pfizer takes $4.4B charge related to cancer drug in fourth-quarter earnings

Pfizer’s Metsera-originated monthly GLP-1 cuts weight by 10.5% at six months

AstraZeneca gets CRL for prefilled pen version of lupus drug Saphnelo

Carbon Health files for bankruptcy, seeking to sell or restructure

First 10 Medicare-negotiated drug prices have taken effect: Are seniors really saving money?